Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs

Clinical Chemistry

Volumn 43, Issue 9, 1997, Pages 1786-1788

  Hoppensteadt, Debra A ^a   Kahn, Steven ^a   Farced, Jawed ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; EFEGATRAN; HEPARIN; HIRUDIN; MACROGOL DERIVATIVE; WARFARIN;

ANTICOAGULANT THERAPY; BLOOD CLOTTING TIME; CONFERENCE PAPER; FIBRIN CLOT; HUMAN; PROTHROMBIN TIME; THROMBOSIS;

EID: 0030870091     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.9.1786     Document Type: Conference Paper

References (3)

1. Scully MF. Automated control of coumarin therapy by chromogenic factor X assay. In: Lijnen H, Collen D, Verstraate M, eds. Synthetic substrates in clinical blood coagulation assays (Developments in hematology, Vol. 1). UK: Martinus Nijhoff Publ., 1980:27-31.
2. Bergstram K, Egberg N. Determination of Vitamin K sensitive coagulation factors in plasma. Studies on three methods using synthetic chromogenic substrates. Thromb Res 1978;12:531-47.
3. Erskine JG, Walker ID, Davidson JF. Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X. J Clin Pathol 1980:33:445-8.